AU2018900108A0 - Proteinaceous molecules and uses therefor - Google Patents

Proteinaceous molecules and uses therefor

Info

Publication number
AU2018900108A0
AU2018900108A0 AU2018900108A AU2018900108A AU2018900108A0 AU 2018900108 A0 AU2018900108 A0 AU 2018900108A0 AU 2018900108 A AU2018900108 A AU 2018900108A AU 2018900108 A AU2018900108 A AU 2018900108A AU 2018900108 A0 AU2018900108 A0 AU 2018900108A0
Authority
AU
Australia
Prior art keywords
uses therefor
proteinaceous molecules
proteinaceous
molecules
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900108A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Canberra
Original Assignee
University of Canberra
Filing date
Publication date
Application filed by University of Canberra filed Critical University of Canberra
Publication of AU2018900108A0 publication Critical patent/AU2018900108A0/en
Priority to PCT/AU2019/050025 priority Critical patent/WO2019136532A1/en
Priority to JP2020558659A priority patent/JP7236164B2/en
Priority to SG11202006459XA priority patent/SG11202006459XA/en
Priority to JP2020558658A priority patent/JP2021510538A/en
Priority to PCT/AU2019/050024 priority patent/WO2019136531A1/en
Priority to CA3087779A priority patent/CA3087779A1/en
Priority to AU2019207535A priority patent/AU2019207535B2/en
Priority to EP19738973.7A priority patent/EP3740496A4/en
Priority to SG11202006441SA priority patent/SG11202006441SA/en
Priority to CN201980019151.2A priority patent/CN111936509A/en
Priority to CA3087761A priority patent/CA3087761A1/en
Priority to CN201980019179.6A priority patent/CN111936857B/en
Priority to US16/962,181 priority patent/US20210055302A1/en
Priority to US16/962,167 priority patent/US20200339691A1/en
Priority to EP19738581.8A priority patent/EP3740756A4/en
Priority to AU2019207534A priority patent/AU2019207534B2/en
Abandoned legal-status Critical Current

Links

AU2018900108A 2018-01-15 2018-01-15 Proteinaceous molecules and uses therefor Abandoned AU2018900108A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AU2019207534A AU2019207534B2 (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor
AU2019207535A AU2019207535B2 (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy
CN201980019151.2A CN111936509A (en) 2018-01-15 2019-01-15 Protein molecules and uses thereof
SG11202006459XA SG11202006459XA (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor
JP2020558658A JP2021510538A (en) 2018-01-15 2019-01-15 Protein molecules and their use
PCT/AU2019/050024 WO2019136531A1 (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor
CA3087779A CA3087779A1 (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy
PCT/AU2019/050025 WO2019136532A1 (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy
EP19738973.7A EP3740496A4 (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor
SG11202006441SA SG11202006441SA (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy
JP2020558659A JP7236164B2 (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy
CA3087761A CA3087761A1 (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor
CN201980019179.6A CN111936857B (en) 2018-01-15 2019-01-15 Reagents and methods for predicting response to therapy
US16/962,181 US20210055302A1 (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy
US16/962,167 US20200339691A1 (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor
EP19738581.8A EP3740756A4 (en) 2018-01-15 2019-01-15 Agents and methods for predicting response to therapy

Publications (1)

Publication Number Publication Date
AU2018900108A0 true AU2018900108A0 (en) 2018-01-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP3817822A4 (en) Protein degraders and uses thereof
EP3737666A4 (en) Protein degraders and uses thereof
EP3755325A4 (en) Small molecules for inducing selective protein degradation and uses thereof
EP3684365A4 (en) Protein degraders and uses thereof
EP3906055A4 (en) Multi-specific protein molecules and uses thereof
EP3752612A4 (en) Modified compounds and uses thereof
EP3810182A4 (en) Neoantigens and uses thereof
EP3740496A4 (en) Proteinaceous molecules and uses therefor
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
EP3810180A4 (en) Neoantigens and uses thereof
EP3841096A4 (en) Pyridinylmethylenepiperidine derivatives and uses thereof
EP3444270A4 (en) Novel natural protein and application thereof
EP3630732A4 (en) Method and molecules
EP3997230A4 (en) Claudin-6 binding molecules and uses thereof
EP3794027A4 (en) Optimized gp41-binding molecules and uses thereof
EP3781213A4 (en) Trans-splicing molecules
EP3801505A4 (en) Cannabinoids and uses thereof
EP3762364A4 (en) Pyrrolidineamide derivatives and uses thereof
EP3740228A4 (en) Peptides and uses thereof
EP3688472A4 (en) Conjugated proteins and uses thereof
EP3980563A4 (en) Ntrk fusion molecules and uses thereof
EP3856755A4 (en) Terpinoid derivatives and uses thereof
EP3781204A4 (en) Binding molecules
EP3946431A4 (en) Modified hemoglobin molecules and uses thereof
EP3845606A4 (en) Hydrogel and uses therefor